Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-21-007000

Options or other derivatives

  • EVP, Research & Development acquired 14,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sandrock Alfred · EVP, Research & Development

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-18 Grant or award : show line 1 in the form Restricted Stock Unit +14,500 14,500 D
Loading xslF345X03/form4.xml…